Home Cart Sign in  
Chemical Structure| 937039-45-7 Chemical Structure| 937039-45-7

Structure of Pimelic Diphenylamide 106
CAS No.: 937039-45-7

Chemical Structure| 937039-45-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pimelic diphenylamide 106 is an inhibitor of class I HDAC with IC50 for HDAC1, HDAC2, and HDAC3 of 150 nM, 760nM, and 370 nM, respectively.

Synonyms: Histone Deacetylase Inhibitor VII; TC-H 106; TC-H 106, TC-H106, TC-H-106, TCH-106, TCH 106, TCH106, Histone Deacetylase Inhibitor VII, Pimelic Diphenylamide 106

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pimelic Diphenylamide 106

CAS No. :937039-45-7
Formula : C20H25N3O2
M.W : 339.43
SMILES Code : O=C(NC1=CC=CC=C1N)CCCCCC(NC2=CC=C(C)C=C2)=O
Synonyms :
Histone Deacetylase Inhibitor VII; TC-H 106; TC-H 106, TC-H106, TC-H-106, TCH-106, TCH 106, TCH106, Histone Deacetylase Inhibitor VII, Pimelic Diphenylamide 106
MDL No. :MFCD17010287
InChI Key :WTKBRPXPNAKVEQ-UHFFFAOYSA-N
Pubchem ID :16070100

Safety of Pimelic Diphenylamide 106

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Pimelic Diphenylamide 106

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SH-SY5Y cells 10 μM 24 hours TC-H 106 significantly increased VMAT2 expression in SH-SY5Y cells and elevated dopamine concentrations both intracellularly and in synaptosomes. PMC10517640
GM15850 FRDA lymphoblast cells 2 μM 24 hours Evaluate the effect of 106 on histone H3 acetylation, results showed significant increase in histone H3 acetylation after treatment with 106, which was maintained for several hours after drug removal PMC2602898

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Normal experimental animals Subcutaneous injection 150 mg/kg Once daily for 2 or 4 days TC-H 106 significantly increased VMAT2 expression in Mice brains, particularly in the cerebral cortex, striatum, and substantia nigra regions. PMC10517640
Mice R6/2 Huntington’s disease Mice model Oral administration in drinking water 150 mg/kg Once daily for several months To evaluate the long-term efficacy of 4b in the Huntington’s disease Mice model, showing improved motor performance and overall appearance, and amelioration of body weight loss PMC3433414

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.95mL

0.59mL

0.29mL

14.73mL

2.95mL

1.47mL

29.46mL

5.89mL

2.95mL

References

 

Historical Records

Categories